Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 9 · newest first

  1. Investigating the correlation between cytokine levels and prognostic factors in advanced gastric cancer: A systematic review and meta-analysisCancer Treatment and Research Communications · 2025
  2. Analysis of the relevant factors of lymph node metastasis in No.253 lymph node of rectal cancer patientsCancer Treatment and Research Communications · 2025
  3. Mitigating the side effects of conventional radiotherapy: deep examination of the FLASH effect on human healthy bronchial epithelial cell lineCancer Treatment and Research Communications · 2025
  4. Characteristics, incidence, and survival of unknown stage cancer: A US population-based studyCancer Treatment and Research Communications · 2025
  5. Carfilzomib in relapsed/refractory multiple myeloma patients – real world evidence – experiences of the Croatian cooperative group for hematologic diseases (KROHEM)Cancer Treatment and Research Communications · 2025
  6. Validation of the pheochromocytoma of adrenal gland scaled score (PASS) grading system: A retrospective double-centered cross-sectional studyCancer Treatment and Research Communications · 2025
  7. Bioinformatic-based study to investigate the fluctuations and performance of MYD88 and GRB2 gene expression in gastric cancer; Can they be considered diagnostic biomarkers?Cancer Treatment and Research Communications · 2025
  8. Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non–small-cell lung cancerCancer Treatment and Research Communications · 2025
  9. Mapping the landscape of breast cancer care in Bulgaria: a scoping reviewCancer Treatment and Research Communications · 2025
  10. A systematic literature review of MTAP deletions in solid and hematologic CancersCancer Treatment and Research Communications · 2025
  11. Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical applicationCancer Treatment and Research Communications · 2025
  12. A retrospective analysis of the efficacy and safety of immune combination therapy in driver gene-negative non-small cell lung cancer with brain metastasesCancer Treatment and Research Communications · 2025
  13. Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatmentCancer Treatment and Research Communications · 2025
  14. Ferroptosis as the new approach to cancer therapyCancer Treatment and Research Communications · 2025
  15. Impact of aromatase inhibitors on thyroid function in postmenopausal women with early-stage breast cancer: a prospective controlled studyCancer Treatment and Research Communications · 2025
  16. Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045Cancer Treatment and Research Communications · 2025
  17. Genome-wide cell-free DNA methylation profiling in advanced stage ovarian cancer. Are we looking at the tumor or the patient's immune response to the tumor?Cancer Treatment and Research Communications · 2025
  18. Real-world clinical practice and outcomes in Peruvian patients with advanced EGFR T790M mutation positive NSCLC: A multicenter analysisCancer Treatment and Research Communications · 2025
  19. Correlation between TTF-1 expression and EGFR mutations in moroccan lung adenocarcinoma: A prospective six-year studyCancer Treatment and Research Communications · 2025
  20. Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in SpainCancer Treatment and Research Communications · 2025
  21. A systemic review on chemotherapy induced nausea and vomiting- risk and clinical management with alternative therapiesCancer Treatment and Research Communications · 2025
  22. Evaluation of pancreatic elastase-1 measurement during health checkups for detection of pancreatic cancer in asymptomatic individualsCancer Treatment and Research Communications · 2025
  23. Treatment refractoriness and response rates in patients with relapsed/refractory multiple myeloma: a retrospective analysis of real-world dataCancer Treatment and Research Communications · 2025
  24. Comparing the oncologic outcomes of breast-conserving surgery for breast cancer patients performed either upfront or following neoadjuvant chemotherapy: a matched retrospective cohortCancer Treatment and Research Communications · 2025
  25. Central obesity increases the risk of breast cancer irrespective of menopausal status in women: Systematic review and meta-analysisCancer Treatment and Research Communications · 2025
  26. A randomized controlled trial comparing large versus small stitch incision closure in gynaecological malignancies (CLaSSIC Study)Cancer Treatment and Research Communications · 2025
  27. Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in CanadaCancer Treatment and Research Communications · 2025
  28. New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib eraCancer Treatment and Research Communications · 2025
  29. A comparative study of DEB-TACE alone and DEB-TACE combined with targeted therapy and immunotherapy in the treatment of intermediate-advanced hepatocellular carcinomaCancer Treatment and Research Communications · 2025
  30. The long-term trends in the disease burden of acute Lymphoblastic Leukemia in China from 1990 to 2021 and projections for the next 15 yearsCancer Treatment and Research Communications · 2025
  31. Innovative smart biosensors for cancer theranostics: A new frontier in detection, diagnosis, and beyondCancer Treatment and Research Communications · 2025
  32. Serum Klotho: Unraveling its association with diagnosis and prognosis of breast cancerCancer Treatment and Research Communications · 2025
  33. Therapy gone viral: Exploring the use of oncolytic viruses in non-small cell lung cancer immunotherapyCancer Treatment and Research Communications · 2025
  34. Evaluation of the impact of energy, radiation type, and concentration on dose enhancement by Gold NanoparticlesCancer Treatment and Research Communications · 2025
  35. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer RegistryCancer Treatment and Research Communications · 2025
  36. miR-150 in cancer metastasis: Orchestrating migration, invasion, and angiogenesis through context-dependent mechanismsCancer Treatment and Research Communications · 2025
  37. Trends in breast cancer in Indonesia from 2017 to 2020: A national-level analysis by age and disease severityCancer Treatment and Research Communications · 2025
  38. The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancerCancer Treatment and Research Communications · 2025
  39. Impact of adjuvant therapy on survival in treatment of CNS hemangiopericytomasCancer Treatment and Research Communications · 2025
  40. Factors influencing the diagnostic basis in pancreatic cancer. A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohortCancer Treatment and Research Communications · 2025
  41. The role of dietary sugars in cancer risk: A comprehensive review of current evidenceCancer Treatment and Research Communications · 2025
  42. The role of long non-coding RNAs in developing paclitaxel-resistant triple negative breast cancer: a systematic reviewCancer Treatment and Research Communications · 2025
  43. Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA studyCancer Treatment and Research Communications · 2025
  44. Clonal origins and divergent evolutionary relationships of synchronous multiple malignant neoplasms in gynecology revealed by next-generation sequencingCancer Treatment and Research Communications · 2025
  45. Trop-2 expression as a biomarker of response to sacituzumab govitecan in patients with HER2-negative metastatic breast cancer: A pilot studyCancer Treatment and Research Communications · 2025
  46. Photodynamic therapy with zinc phthalocyanine enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by downregulation of PI3K/AKT/mTOR signaling pathwayCancer Treatment and Research Communications · 2025
  47. Identification of SARS2, PKN1, and IL11RA as causally-associated genes for patients with gastric cancer via immune cell activity: A multi-omics Mendelian randomization study integrating GWAS, eQTL, and pQTL dataCancer Treatment and Research Communications · 2025
  48. Machine learning-based radiomics analysis on contrast-enhanced MRI for prediction of cytotoxic T-lymphocyte associated protein 4 expression in patients with breast cancerCancer Treatment and Research Communications · 2025
  49. Dendrosomal Curcumin Nanoformulation induces apoptosis via Bax/Bcl-2 in human ovarian cancer OVCAR3 cellsCancer Treatment and Research Communications · 2025
  50. The association between surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast conserving therapy: Observational studyCancer Treatment and Research Communications · 2025